- Email: [email protected]
American College of Apothecaries Meeting
Calvin Berger (left), was recipient of the 1964 J. Leon Lascoff Award given by the American College of Apothecaries for "outstanding service to professional pharo macy." With him are Lee E. Eiler (center), chairman ofthe ACA board and APhA councilor, and B.S. Rogers, 1963-64 ACA president.
New officers elected by ACA are (left to right) Minter B. Ralston, Jr., treasurer; William B. Hennessy, vice president; Walter P. Scheffe, president; George A. Raven, president-elect; B.S. Rogers, board chairman, and Robert E. Abrams, executive secretary.
american college of apothecaries meeting pharmacists P rofessionally-minded took a long exploratory look into the future and the challenges that pharmacy might expect when members of the American College of Apothecaries gathered for their annual meeting in Dallas, Texas, October 24-27. The pharmacist has a definite role in spotting and reporting adverse reactions, manufacturers' packaging errors and other health hazards related to drugs, Dr. Joseph F. Sadusk, Jr., medical director of FDA told the group. Participating in a "Drug Safety" panel attended by the public as well as by some 350 pharmacists, he indicated the dispensing pharmacist should notify the appropriate parties which may include prescriber, manufacturer and the district FDA office when such reactions and dangers are detected. Pharmacists should review new package inserts regularly to keep abreast of the rapid changes in drugs and keep a complete reference file in the prescription department, he added. Sharing the spotlight with Dr. Sadusk were Arthur Grollman, chairman of the department of experimental medicine of the University of Texas; Milford Rouse, chairman of the AMA house of delegates; Austin Smith, PMA president, and Robert E. Abrams, ACA executive secretary. Another highlight of the meeting was the panel on "What Lies Ahead" moderated by Wallace Werble, publisher of FDC Reports. The panel covered industry, hospi-
PRE-DOCTORAL FELLOWSHIP Leading to an MS or PhD and Post Doctoral Traineeships in toxicology, pharmacology and drug metabolism will be available starting January 1965 at the University of Miami, School of Medicine in the Dept. of Pharmacology. Applications may be submitted at any time and are invited from candidates who have completed or will shortly complete the requirements for the B.S., M.S. or Ph.D. degrees and who are U.S. citizens. The period of Traineeship is twelve months (including one month's vacation) and may be renewed for additional years. Application forms and information may be obtained by writing to: Dr. Kenneth F. Lampe, Program Director, 1600 N. W. 10th Avenue, Miami, Fla.
616
tal complex, welfare programs, education and legislation. On this panel the Reverend Bolton Boone, administrator of the Methodist Hospital in Dallas, told the group that the public is beginning to consider its community hospital as its own health center because there are greater public demands for hospital service and there is a tendency for physicians to remain close to hospital facilities. To meet the challenges of the future, he suggested pharmacists, doctors and hospital administrators assume leadership and help fashion modern health care programs or else they will "curse the change that is surging about us and await the day when organizations and influences other than our own will tell us what to do." Dean Linwood Tice of the Philadelphia College of Pharmacy and Science and Arthur Tye of Ohio State University college of pharmacy presented four "continuing Education" lectures covering new drugs, progestational agents, pharmacologic incompatibilities and biopharmaceutics. Tye noted that the pharmacist is "extremely important" in protecting the public against untoward results arising from use and abuse of drugs and urged pharmacists to keep adequate patient medication records as a safeguard. ACA Fellows Lee E. Eiler of Dayton, Ohio, Terryl R. Ensign of Manistee, Michigan and Eugene V. White of Berryville, Virginia also describes the use of such patient records in their pharmacies in a panel program entitled, "This Works for Me." Calling on the communications field for an examination of the pharmacy profession, ACA members heard an address by Richard West, assistant editor of the Dallas Morning News, discussing free enterprise and health care. Rounding out the varied program was a symposium on the role of the community pharmacist in planning community mental health programs, discussions on the pharmacist's responsibility in self-medication and to his associations, and a look at the public's attitude on health service. Installed as the new ACA president was Walter P. Scheffe. He succeeded B.S. Rogers who was named chairman of the board of directors. Other officers elected were George A. Raven, president-elect;
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
William B. Hennessy, vice president; Robert E. Abrams, executive secretary, and Minter B. Ralston, Jr., treasurer. Charles V. Selby of Clarksburg, West Virginia, treasurer of ACA since in 1940, became treasurer emeritus. Calvin Berger, past chairman of the APHA House of Delegates, received the J. Leon Lascoff Memorial Award. Pharmacist Berger is a founder and past president of ACA and a member and past chairman of the New York State Board of Pharmacy. In presenting the award President B.S. Rogers cited the recipient's "outstanding service to professional pharmacy." In concluding its sessions the group approved several resolutions which~ called on FDA to see that information
is sent to pharmacy practitioners prior to or at least at the same time new information is made available to physicians concerning drug status, utilization and toxicity. ~ asked FDA to require the labeling of proprietary pharmaceutical products to indicate the quantity of ingredients (Present FDA regulations permit products to be marketed without disclosing the amount of some ingredients and this constitutes a serious hazard to public health). ~ urged APhA to press for introduction of legislation in the next Congress for a reclassification of drugs, citing the need for such legislation and the fact that it is in the public health interest. ~ urged ACA Fellows to incorporate two functions into their practicesmaintaining patient prescription record cards and developing an effective community health education program by participating in APhA's "Health Education Center Service." ~ expressed concern over the dispensing of drugs in hospitals where proper pharmaceutical direction and control are lacking (The group voted to foster programs to insure adequate pharmaceutical service ~n all hospitals and explore seminar and information programs whereby community pharmacists can be assisted in furnishing such service to smaller hospitals.) ~ endorsed the concept of providing care for the mentally ill in their own community wherever possible and urged Fellows to participate in planning groups developing community mental health programs and facilities under federalstate planning programs. •
New officers elected by ACA are (left to right) Minter B. Ralston, Jr., treasurer; William B. Hennessy, vice president; Walter P. Scheffe, president; George A. Raven, president-elect; B.S. Rogers, board chairman, and Robert E. Abrams, executive secretary.
american college of apothecaries meeting pharmacists P rofessionally-minded took a long exploratory look into the future and the challenges that pharmacy might expect when members of the American College of Apothecaries gathered for their annual meeting in Dallas, Texas, October 24-27. The pharmacist has a definite role in spotting and reporting adverse reactions, manufacturers' packaging errors and other health hazards related to drugs, Dr. Joseph F. Sadusk, Jr., medical director of FDA told the group. Participating in a "Drug Safety" panel attended by the public as well as by some 350 pharmacists, he indicated the dispensing pharmacist should notify the appropriate parties which may include prescriber, manufacturer and the district FDA office when such reactions and dangers are detected. Pharmacists should review new package inserts regularly to keep abreast of the rapid changes in drugs and keep a complete reference file in the prescription department, he added. Sharing the spotlight with Dr. Sadusk were Arthur Grollman, chairman of the department of experimental medicine of the University of Texas; Milford Rouse, chairman of the AMA house of delegates; Austin Smith, PMA president, and Robert E. Abrams, ACA executive secretary. Another highlight of the meeting was the panel on "What Lies Ahead" moderated by Wallace Werble, publisher of FDC Reports. The panel covered industry, hospi-
PRE-DOCTORAL FELLOWSHIP Leading to an MS or PhD and Post Doctoral Traineeships in toxicology, pharmacology and drug metabolism will be available starting January 1965 at the University of Miami, School of Medicine in the Dept. of Pharmacology. Applications may be submitted at any time and are invited from candidates who have completed or will shortly complete the requirements for the B.S., M.S. or Ph.D. degrees and who are U.S. citizens. The period of Traineeship is twelve months (including one month's vacation) and may be renewed for additional years. Application forms and information may be obtained by writing to: Dr. Kenneth F. Lampe, Program Director, 1600 N. W. 10th Avenue, Miami, Fla.
616
tal complex, welfare programs, education and legislation. On this panel the Reverend Bolton Boone, administrator of the Methodist Hospital in Dallas, told the group that the public is beginning to consider its community hospital as its own health center because there are greater public demands for hospital service and there is a tendency for physicians to remain close to hospital facilities. To meet the challenges of the future, he suggested pharmacists, doctors and hospital administrators assume leadership and help fashion modern health care programs or else they will "curse the change that is surging about us and await the day when organizations and influences other than our own will tell us what to do." Dean Linwood Tice of the Philadelphia College of Pharmacy and Science and Arthur Tye of Ohio State University college of pharmacy presented four "continuing Education" lectures covering new drugs, progestational agents, pharmacologic incompatibilities and biopharmaceutics. Tye noted that the pharmacist is "extremely important" in protecting the public against untoward results arising from use and abuse of drugs and urged pharmacists to keep adequate patient medication records as a safeguard. ACA Fellows Lee E. Eiler of Dayton, Ohio, Terryl R. Ensign of Manistee, Michigan and Eugene V. White of Berryville, Virginia also describes the use of such patient records in their pharmacies in a panel program entitled, "This Works for Me." Calling on the communications field for an examination of the pharmacy profession, ACA members heard an address by Richard West, assistant editor of the Dallas Morning News, discussing free enterprise and health care. Rounding out the varied program was a symposium on the role of the community pharmacist in planning community mental health programs, discussions on the pharmacist's responsibility in self-medication and to his associations, and a look at the public's attitude on health service. Installed as the new ACA president was Walter P. Scheffe. He succeeded B.S. Rogers who was named chairman of the board of directors. Other officers elected were George A. Raven, president-elect;
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
William B. Hennessy, vice president; Robert E. Abrams, executive secretary, and Minter B. Ralston, Jr., treasurer. Charles V. Selby of Clarksburg, West Virginia, treasurer of ACA since in 1940, became treasurer emeritus. Calvin Berger, past chairman of the APHA House of Delegates, received the J. Leon Lascoff Memorial Award. Pharmacist Berger is a founder and past president of ACA and a member and past chairman of the New York State Board of Pharmacy. In presenting the award President B.S. Rogers cited the recipient's "outstanding service to professional pharmacy." In concluding its sessions the group approved several resolutions which~ called on FDA to see that information
is sent to pharmacy practitioners prior to or at least at the same time new information is made available to physicians concerning drug status, utilization and toxicity. ~ asked FDA to require the labeling of proprietary pharmaceutical products to indicate the quantity of ingredients (Present FDA regulations permit products to be marketed without disclosing the amount of some ingredients and this constitutes a serious hazard to public health). ~ urged APhA to press for introduction of legislation in the next Congress for a reclassification of drugs, citing the need for such legislation and the fact that it is in the public health interest. ~ urged ACA Fellows to incorporate two functions into their practicesmaintaining patient prescription record cards and developing an effective community health education program by participating in APhA's "Health Education Center Service." ~ expressed concern over the dispensing of drugs in hospitals where proper pharmaceutical direction and control are lacking (The group voted to foster programs to insure adequate pharmaceutical service ~n all hospitals and explore seminar and information programs whereby community pharmacists can be assisted in furnishing such service to smaller hospitals.) ~ endorsed the concept of providing care for the mentally ill in their own community wherever possible and urged Fellows to participate in planning groups developing community mental health programs and facilities under federalstate planning programs. •